China Neuroblastoma Treatment Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Neuroblastoma Treatment Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Neuroblastoma Treatment Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Neuroblastoma Treatment Overall Market Size
2.1 China Neuroblastoma Treatment Market Size: 2021 VS 2027
2.2 China Neuroblastoma Treatment Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuroblastoma Treatment Players in China Market
3.2 Top China Neuroblastoma Treatment Companies Ranked by Revenue
3.3 China Neuroblastoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Neuroblastoma Treatment Companies in China Market, by Revenue in 2020
3.5 Companies Neuroblastoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuroblastoma Treatment Players in China Market
3.6.1 List of Tier 1 Neuroblastoma Treatment Companies in China
3.6.2 List of Tier 2 and Tier 3 Neuroblastoma Treatment Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Neuroblastoma Treatment Market Size Markets, 2021 & 2027
4.1.2 Combination Chemotherapy
4.1.3 Monoclonal Antibody Therapy
4.1.4 Vaccine Therapy
4.1.5 Chimeric Antigen Receptor T-Cell Immunotherapy
4.1.6 Oncolytic Virus Therapy
4.2 By Type - China Neuroblastoma Treatment Revenue & Forecasts
4.2.1 By Type - China Neuroblastoma Treatment Revenue, 2016-2021
4.2.2 By Type - China Neuroblastoma Treatment Revenue, 2022-2027
4.2.3 By Type - China Neuroblastoma Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Neuroblastoma Treatment Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - China Neuroblastoma Treatment Revenue & Forecasts
5.2.1 By Application - China Neuroblastoma Treatment Revenue, 2016-2021
5.2.2 By Application - China Neuroblastoma Treatment Revenue, 2022-2027
5.2.3 By Application - China Neuroblastoma Treatment Revenue Market Share, 2016-2027
6 Neuroblastoma Treatment Companies Profiles
6.1 Seattle Children's
6.1.1 Seattle Children's Company Details
6.1.2 Seattle Children's Business Overview
6.1.3 Seattle Children's Neuroblastoma Treatment Introduction
6.1.4 Seattle Children's Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.1.5 Seattle Children's Recent Developments
6.2 CureSearch
6.2.1 CureSearch Company Details
6.2.2 CureSearch Business Overview
6.2.3 CureSearch Neuroblastoma Treatment Introduction
6.2.4 CureSearch Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.2.5 CureSearch Recent Developments
6.3 Texas Children's
6.3.1 Texas Children's Company Details
6.3.2 Texas Children's Business Overview
6.3.3 Texas Children's Neuroblastoma Treatment Introduction
6.3.4 Texas Children's Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.3.5 Texas Children's Recent Developments
6.4 NANT
6.4.1 NANT Company Details
6.4.2 NANT Business Overview
6.4.3 NANT Neuroblastoma Treatment Introduction
6.4.4 NANT Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.4.5 NANT Recent Developments
6.5 Sino Biopharmaceutical
6.5.1 Sino Biopharmaceutical Company Details
6.5.2 Sino Biopharmaceutical Business Overview
6.5.3 Sino Biopharmaceutical Neuroblastoma Treatment Introduction
6.5.4 Sino Biopharmaceutical Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.5.5 Sino Biopharmaceutical Recent Developments
6.6 Jiangsu Hengrui Medicine Co.,Ltd.
6.6.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Details
6.6.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
6.6.3 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Introduction
6.6.4 Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.6.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
6.7 Fosun Pharmaceutical
6.7.1 Fosun Pharmaceutical Company Details
6.7.2 Fosun Pharmaceutical Business Overview
6.7.3 Fosun Pharmaceutical Neuroblastoma Treatment Introduction
6.7.4 Fosun Pharmaceutical Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.7.5 Fosun Pharmaceutical Recent Developments
6.8 Novartis
6.8.1 Novartis Company Details
6.8.2 Novartis Business Overview
6.8.3 Novartis Neuroblastoma Treatment Introduction
6.8.4 Novartis Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.8.5 Novartis Recent Developments
6.9 Juno Therapeutics
6.9.1 Juno Therapeutics Company Details
6.9.2 Juno Therapeutics Business Overview
6.9.3 Juno Therapeutics Neuroblastoma Treatment Introduction
6.9.4 Juno Therapeutics Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.9.5 Juno Therapeutics Recent Developments
6.10 Kite Pharma
6.10.1 Kite Pharma Company Details
6.10.2 Kite Pharma Business Overview
6.10.3 Kite Pharma Neuroblastoma Treatment Introduction
6.10.4 Kite Pharma Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.10.5 Kite Pharma Recent Developments
6.11 Adaptimmune
6.11.1 Adaptimmune Company Details
6.11.2 Adaptimmune Business Overview
6.11.3 Adaptimmune Neuroblastoma Treatment Introduction
6.11.4 Adaptimmune Neuroblastoma Treatment Revenue in China Market (2016-2021)
6.11.5 Adaptimmune Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of TablesTable 1. Neuroblastoma Treatment Market Opportunities & Trends in China Market
Table 2. Neuroblastoma Treatment Market Drivers in China Market
Table 3. Neuroblastoma Treatment Market Restraints in China Market
Table 4. Key Players of Neuroblastoma Treatment in China Market
Table 5. Top Neuroblastoma Treatment Players in China Market, Ranking by Revenue (2019)
Table 6. China Neuroblastoma Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Neuroblastoma Treatment Revenue Share by Companies, 2016-2021
Table 8. Companies Neuroblastoma Treatment Product Type
Table 9. List of Tier 1 Neuroblastoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Neuroblastoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Neuroblastoma Treatment Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Neuroblastoma Treatment Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Neuroblastoma Treatment Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Neuroblastoma Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Neuroblastoma Treatment Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Neuroblastoma Treatment Revenue (US$, Mn), 2022-2027
Table 17. Seattle Children's Company Details
Table 18. Seattle Children's Business Overview
Table 19. Seattle Children's Neuroblastoma Treatment Product
Table 20. Seattle Children's Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Seattle Children's Recent Developments
Table 22. CureSearch Company Details
Table 23. CureSearch Business Overview
Table 24. CureSearch Neuroblastoma Treatment Product
Table 25. CureSearch Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 26. CureSearch Recent Developments
Table 27. Texas Children's Company Details
Table 28. Texas Children's Business Overview
Table 29. Texas Children's Neuroblastoma Treatment Product
Table 30. Texas Children's Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Texas Children's Recent Developments
Table 32. NANT Company Details
Table 33. NANT Business Overview
Table 34. NANT Neuroblastoma Treatment Product
Table 35. NANT Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 36. NANT Recent Developments
Table 37. Sino Biopharmaceutical Company Details
Table 38. Sino Biopharmaceutical Business Overview
Table 39. Sino Biopharmaceutical Neuroblastoma Treatment Product
Table 40. Sino Biopharmaceutical Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Sino Biopharmaceutical Recent Developments
Table 42. Jiangsu Hengrui Medicine Co.,Ltd. Company Details
Table 43. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
Table 44. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Product
Table 45. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Jiangsu Hengrui Medicine Co.,Ltd. Recent Developments
Table 47. Fosun Pharmaceutical Company Details
Table 48. Fosun Pharmaceutical Business Overview
Table 49. Fosun Pharmaceutical Neuroblastoma Treatment Product
Table 50. Fosun Pharmaceutical Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Fosun Pharmaceutical Recent Developments
Table 52. Novartis Company Details
Table 53. Novartis Business Overview
Table 54. Novartis Neuroblastoma Treatment Product
Table 55. Novartis Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Novartis Recent Developments
Table 57. Juno Therapeutics Company Details
Table 58. Juno Therapeutics Business Overview
Table 59. Juno Therapeutics Neuroblastoma Treatment Product
Table 60. Juno Therapeutics Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Juno Therapeutics Recent Developments
Table 62. Kite Pharma Company Details
Table 63. Kite Pharma Business Overview
Table 64. Kite Pharma Neuroblastoma Treatment Product
Table 65. Kite Pharma Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 66. Kite Pharma Recent Developments
Table 67. Adaptimmune Company Details
Table 68. Adaptimmune Business Overview
Table 69. Adaptimmune Neuroblastoma Treatment Product
Table 70. Adaptimmune Neuroblastoma Treatment Revenue in China Market (2016-2021) & (US$ Million)
Table 71. Adaptimmune Recent Developments
List of FiguresFigure 1. Neuroblastoma Treatment Segment by Type
Figure 2. Neuroblastoma Treatment Segment by Application
Figure 3. China Neuroblastoma Treatment Market Overview: 2020
Figure 4. China Neuroblastoma Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Neuroblastoma Treatment Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Neuroblastoma Treatment Revenue in 2020
Figure 7. By Type - China Neuroblastoma Treatment Revenue Market Share, 2016-2027
Figure 8. By Application - China Neuroblastoma Treatment Revenue Market Share, 2016-2027
Figure 9. Seattle Children's Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. CureSearch Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Texas Children's Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. NANT Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Sino Biopharmaceutical Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Jiangsu Hengrui Medicine Co.,Ltd. Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Fosun Pharmaceutical Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Novartis Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Juno Therapeutics Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Kite Pharma Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Adaptimmune Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)